期刊文献+

颌面部VX2肿瘤DCE-MRI与乏氧程度及VEGF表达的相关性研究 被引量:2

DCE-MRI study of maxillofacial VX2 tumors and its relationship between tumor hypoxia and VEGF expression
在线阅读 下载PDF
导出
摘要 目的分析颌面部VX2肿瘤DCE-MRI动态曲线与肿瘤乏氧染色和血管内皮生长因子(VEGF)表达水平的相关性,探讨DCE-MRI在肿瘤乏氧评价中的价值。方法8只新西兰大白兔于单侧颌面部咬肌内接种VX2肿瘤细胞0.5ml,接种后10天开始,每隔2天取一只荷瘤兔行DCE-MRI检查,绘制肿瘤动态增强曲线,计算最大强化率(MER)和强化率斜率(SLE)值。对处死的荷瘤兔,取对应层面病理标本行HE染色、乏氧染色和VEGF染色分析。结果8只实验兔成瘤率达100%,肿瘤位于单侧咬肌内,呈实质性,边缘较清晰;肿瘤MER值与乏氧程度行Spearman's等级相关分析存在显著负相关(P<0.01);肿瘤SLE值与VEGF表达水平存在正相关(P<0.05)。对肿瘤乏氧染色及VEGF表达行连续切片对照研究,发现乏氧染色阳性的区域,VEGF表达也相对较高;但VEGF表达阳性区并不完全与肿瘤乏氧区表达一致。结论肿瘤乏氧与VEGF表达关系密切,乏氧可诱导VEGF表达的增高,而VEGF表达能促进肿瘤血管生成。DCE-MRI动态增强参数与肿瘤乏氧程度和VEGF表达水平有很好的相关性。 To analyze the correlation of dynamic contrast-enchanced MR imaging (DCE MRI) with tumor hypoxia and vascular endothelial growth factor (VEGF) expression and to evaluate the value of DCE-MRI in tumor hypoxia im aging. Methods Eight New Zealand rabbits were inoculated with 0.5 ml (1 × 10^8/ml) VX2 tumor cells in the maxillofacial masseter. DCE-MRI was performed every 2 days since the 10th day on. The maximal enhancement ratio (MER) and slope of enhancement (SLE) were calculated. After DCE MRI, the rabbit was sacrificed and the corresponding tumor specimen was harvested. HE staining, hypoxia and VEGF immunohistochemical staining were carried out. Results All the 8 rabbits had tumors growing. The masses located in the unilateral masseters, and had relatively clear margins. MER had a negative correlation with tumor hypoxia degree (P〈0.01). SLE bore a positive correlation with VEGF immunohistochemical score (P〈 0.05). We compared the continuous sections of hypoxia with VEGF staining of the tumor, and found that where the more hypoxia staining positive, the stronger VEGF expression. But VEGF staining was not always coincident with the staining of hypoxia. Conclusion Tumor hypoxia had a close relationship with the expression of VEGF, and VEGF could promote tumor angiogenesis. DCE MRI had a good correlation with tumor hypoxia degree and VEGF expression.
出处 《中国医学影像技术》 CSCD 北大核心 2005年第11期1644-1647,共4页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金资助(30170286) 上海市卫生局科学技术发展基金资助(01436)
关键词 磁共振成像 图像增强 VX2肿瘤 乏氧 血管内皮生长因子 Magnetic resonance imaging~ Image enehaneement VX2 tumor Hypoxia Vascular endothelial growth factor
  • 相关文献

参考文献12

  • 1Cooper RA, Carrington BM, Loncaster JA, et al. Tumor oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix[J]. Radiother Oncol,2000,57(1):53-59.
  • 2Kaanders JH, Wijffels KI, Marres HA, et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck vancer[J]. Cancer Res,2002,62(23):7066-7074.
  • 3Bottaro DP, Liotta LA. Out of air is not out of action[J]. Nature,2003,423(6940):593-595.
  • 4Gerber HP, Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis[J].J Mol Med,2003,81(1):20-31.
  • 5Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors[J]. J Magn Reson Imaging,1999,10(3):260-266.
  • 6Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma:characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement[J]. Cancer Res,1997,57(21):4777-4788.
  • 7Buckley DL, Drew PJ, Mussurakis S, et al. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI[J].J Magn Reson Imaging,1997,7(3):461-464.
  • 8Lyng H, Vorren AO, Sundfor K, et al. Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA enhanced MR imaging[J]. J Magn Reson Imaging,2001,14(6):750-756.
  • 9Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma:comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival[J]. Cancer Res,1998,58(16):3598-3602.
  • 10Wong RKW, Fyles A, Milosevic M, et al. Heterogeneity of polargraphic oxygen tension measurements in cervix cancer: an evalnation of within and between tumor variability, probe position and trace depth[J]. Int J Radiat Oncol Biol Phys,1997,39(2):405-412.

同被引文献22

  • 1张景峰,王仁法,李勇刚,张伶,王承缘,夏黎明.兔VX2软组织肿瘤模型的建立与MR灌注成像研究[J].中国医学计算机成像杂志,2004,10(6):417-420. 被引量:4
  • 2屈三甫,刘红芬,郑从义,沈超.VX-2鳞癌组织的超低温长期保存[J].肿瘤防治研究,2005,32(3):183-183. 被引量:3
  • 3李玉洁,张贵祥,胡运胜,赵京龙.颌面部VX2肿瘤动物模型的建立及其磁共振表现[J].中华耳鼻咽喉头颈外科杂志,2006,41(3):220-221. 被引量:5
  • 4Timke C, Zieher H, Roth A, et al. Combination of vascular endothelial growth factor receptor/platelet-derivcd growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res, 2008,14(7):2210-2219.
  • 5Hicklin DJ, Ellis LM. Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis [J]. J Clin Oncol, 2005,23(5): 1011-1027.
  • 6Gasparini G, Longo R, Fanelli M,et al. Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions[J]. J Clin Oncol, 2005,23(6): 1295-1311.
  • 7Soltau J, Drevs J. Mode of action and clinical impact of VEGF signaling inhibitors. Expert Rev Anticancer Ther, 2009,9(5):649-662.
  • 8Gupta VK, Jaskowiak NT, Beckett MA,et al. Vascular endothelial growth factor enhances endothelial cell survival and tumor radiorcsistance. Cancer J. 2002, 8(1):47-54.
  • 9Medina MA, Munoz-Chapuli R, Quesada AR. Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope[J]. J CeU Mol Med, 2007,11(3):374-382.
  • 10Ning S,Laird D,Cherrington JM,et al.The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation[J].Radiat Res,2002,157(1 ):45-51.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部